October 2014 FDA Recall Emtriva by Gilead Sciences, Inc.
D-0045-2015 - Defective Container; leaking around the cap

This Class II drug recall was voluntarily initiated by Gilead Sciences, Inc. on October 1, 2014 for the product Emtriva. The FDA reported the reason for recall as defective container; leaking around the cap. The product was distributed in United States, Puerto Rico, Fiji. and the recall is currently terminated.

Recall Number: D-0045-2015

Reason for Recall
Defective Container; leaking around the cap
Initiated
10-01-2014
Reported
11-05-2014
Quantity
6,290 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Gilead Sciences, Inc.
United States, Puerto Rico, Fiji.
Emtriva (emtricitabine) Oral Solution, 10 mg/mL, 170 mL bottles, Rx only, Manufactured for Gilead Sciences, Inc., Foster City, CA NDC 61958-0602-1 Gilead Sciences, Inc. Foster City, CA 94404.

Batch or Lot Expiration Information

Lot# FG Lot Number: HDNTD1 and HDNTD exp 30-Jun-15, KCMGD and KCMGD1 exp 31-Oct-15, KYGHA, KYGKA and KYGKK exp 30-Apr-16, MZVBA and MZTZA exp 31-Oct-16

Affected Packages Involved in this Recall